Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e

Size: px
Start display at page:

Download "Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e"

Transcription

1 Pathology #07 Mature B-Cell Neoplasm Hussein Al-Sa di Dr. Sohaib Al-Khatib 0 P a g e Thursday 18/2/2016

2 Our lecture today (with the next 2 lectures) will be about lymphoid tumors This is a little bit long lecture (56 minutes)... but don t get upset, you can finish it like any other lecture. Lymphoid neoplasms are either: Lymphoma: mature cell neoplasm. OR Leukemia: immature (primitive) cell neoplasms However, there re exceptions. An example of that is Hairy cell leukemia which consists of mature B cell lymphocytes But why is it called Leukemia?! Because of the presentation (site of involvement). Previously, they used to classify neoplasms as leukemia if they involve the bone marrow and the peripheral blood, and as lymphoma if they involve lymph nodes. So because hairy cell leukemia involves bone marrow and the peripheral blood, they thought that it s leukemia and kept the name to avoid confusing people. So again Lymphoma tumor of mature cells lymph nodes involvement &it may disseminate to bone marrow Leukemia tumor of immature cells Bone marrow & peripheral blood involvement With some exceptions like the one mentioned above * Lymphoma Lymph: lymphatic tissue oma: mass, so mass arising from the lymphatic tissue. * Leukemia Leuk: white; whitening of the blood because of the many circulating abnormal lymphocytes... so the color of the blood becomes faint red which is whiter emia: blood Example: Follicular lymphoma: It s a lymphoma because it arises from lymph nodes, and because it forms follicles it s called follicular. 1 P a g e

3 Now if you have a patient with follicular lymphoma and a bone marrow involvement (because as we said lymphoma may disseminate to bone marrow), do we call it follicular leukemia? No we just call it lymphoma with a bone marrow metastasis What if you have a patient with leukemia and lymph node involvement? It s leukemia with lymph node metastasis (not lymphoma). Now let s take a lookat lymph node anatomy (study it carefully) How do you differentiate between the lymph node and any lymphoid tissue? If it has a capsule it s a lymph node, otherwise it s a lymphoid tissue. In the figure you can see: - The capsule. - Beneath the capsule there is a sub-capsular sinus, which is opened to allow lymph to pass through it. - The Marginal zonecontains B lymphocytes. - Mantle Zone - In the Medulla there re sinuses. - The Paracortex area contains T-Lymphocytes - Cortex: containslymphoid follicles which in turn contains B-lymphocytes 2 P a g e

4 These lymphoid follicles may be active (primitive) or inactive (secondary). How can we differentiate between active and inactive follicles? Through the presence of the Germinal center. If it s present, the follicle is active, if not it s inactive. Why would a follicle to be active? Because of the exposure to antigens, and that leads to its activation along with the germinal center formation. In the germinal center, B lymphocyte maturation, immunoglobulins production and class switching occur. But What is class switching? Our body produces millions of immunoglobulins (IgG, IgM etc.) in response to the unlimited number of antigens it encounters. After the production of these immunoglobulins, there will be a switching from one class to another. Immunoglobulin class switching: is a biological mechanism that changes a B cell's production of immunoglobulin (antibodies) from one type to another, such as from the IgM to the IgG. The antibody retains affinity for the same antigens, but can interact with different effector molecules. (From Wikipedia) All these processes occur in the germinal center. Why is it important to know the anatomy and the structure of lymph nodes? Because Lymphoma is named according to its cell of origin. For example: - Lymphoma arising from lymph node follicle is called follicular lymphoma - Lymphoma arising from mantle zone is called mantle cell lymphoma - Lymphoma arising from the marginal zone is called marginal cell lymphoma. 3 P a g e

5 We can differentiate between these different types of lymphoma by: looking at the site of expansion of the lymphoma, cellular morphology and antigen expression. For example, cells in the germinal center of lymphoid follicles express antigens different from those expressed on mantle cells: Cells (B lymphocytes) in the germinal center of lymphoid follicles express CD10 antigen. (CD: cluster of differentiation).remember this point Different antigens are given names but it s difficult to remember them since there re many of them, so they re given numbers. T lymphocytes express either CD4 (T helper cell)or CD8 (cytotoxic T cell). So, if you have a tumor composed of lymphocytes and you do CD test. If the cells are CD4 positive, what does that mean? It means that the tumor is composed of mature T lymphocyte, it could be T cell lymphoma or T cell leukemia. There re common markers for T lineage and others for B lineage: (A marker if present on the surface of a cell it tells us what that cell is) 1) The common markers for T linage are: - CD3, it s specific for T lymphocyte - CD4 &CD8 are also markers for T lymphocytes but are NOT specific like CD3 2) The common markers for B lymphocytes are: - CD10 - CD19 - CD20 - CD22 You have to remember these markers. 4 P a g e

6 ? On what cell can you find CD10? On B lymphocyte within lymphoid follicles (germinal center). So as we said follicular lymphoma arising from the lymphoid follicles should express CD10. This is a section of a lymph node Notice: - The germinal center within the lymphoid follicles - Mantle zone - The marginal zone You have many lymph nodes throughout your body. The stage of lymphoma is determined according to the number and sites of lymph nodes involved. If a 10 year old kid with cervical lymph nodes enlargement of one week duration complaining of fever, what should think of? It s Infection! It could be tonsillitis, dental caries, infectious mononucleosis etc. Lymph node enlargement(also called Lymphadenopathy)could be: Monoclonal: tumor (lymphoma) or Reactive: non-monoclonal; nontumorous especially in children if it s localized and acute. Acute or chronic (persistent) Associated or not associated with fever. Generalized or Localized 5 P a g e

7 If Persistent and Generalized enlargement = you should think of lymphoma or chronic infection. Acute and localized = infection You have to know the classification because it determines what you will do next. For example, that kid with cervical lymph node enlargement, if this enlargement is due to infection (tonsillitis) you may give him antibiotic after doing the culture and swap and see him after 2 weeks. However, if you re thinking of lymphoma, you should do other appropriate procedures. So there re many causes of lymphadenopathy: Not always you have to do biopsy and detailed lab tests you have to have an approach see the diagram next page: If you have a patient with lymphadenopathy, are you going to reassure to the parents?! It depends on the situation: If it s infection you can reassure the family. If it s not an infection, look for significant physical signs and symptoms like sweating, weight loss, generalized weakness, generalized lymphadenopathy (cervical, axillary, abdominal etc.).. These signs are alarming If these signs are present, you should investigate and sometimes you do a lymph node biopsy. If no significant signs and symptoms present, you can observe and use antibiotic, and see the patient again after a period of time. * Usually, painful enlarged lymph node indicates infection, but this is not the rule always. 6 P a g e

8 yes you can go through this page quickly :3 7 P a g e Definition Lymphoma: is a tumor arising of mature B or T lymphocytes, usually in the lymph nodes

9 In general, Lymphoma is classified into Hodgkin and non-hodgkin lymphoma. Hodgkin is a name of a scientist - Hodgkin lymphoma has 5 subtypes - Non-Hodgkin lymphoma have many subtypes including B & T lymphoma What causes cancer? Genetic defects, especially those involving translocation between genes on different chromosomes. Knowing translocation is very important because it enable us to confirm the diagnosis. If you look at the table, you can notice that chromosome #14 is involved in most translocation WHY??? Because chromosome #14 harbors a promotor for immunoglobulin H synthesis. 8 P a g e

10 Recall that one of the identifying characteristic of tumors is its uncontrolled rapid growth. So what drives the normal lymphocyte to be abnormal is a genetic defect that affects the fate of this lymphocyte. Chromosome #14 has a promotor for immunoglobulin H gene which is (the promotor) consistently active to continuously produce immunoglobulins against different antigens that your body encounters through your daily life. Examples: (You have to remember them) Translocation of bcl-2 gene with IgHgenes in t(14:18): On chromosome #14 there s the bcl-2 gene which is an anti-apoptotic gene so this translocation will put bcl-2 gene under the control of immunoglobulin promotor induce the expression of bcl-2 more and more no apoptosis tumor (Follicular lymphoma&dlbcl (Diffuse Large B-Cell Lymphoma)) Translocation of Cyclin D1(bcl-1) gene with IgH gene int(11:14): You put cyclin D (bcl-1) under the immunoglobulin promotor induce cell proliferation Mantle cell lymphoma t(11:18) & t(1:14) Malt lymphoma t(9:14) Lymphoplasmocytic lymphoma Burkitt lymphoma : - t(8:14) - t(2:8) - t(8:22) Also, chromosomes #2&#22 harbor active promotor like that of #14. #14: IgH #2: IgK #22: Igλ So you will find translocation of these chromosomes with other chromosomes. And genes which become under the control of these promoters will be more active tumor. 9 P a g e

11 B Lymphocytes mature in lymph nodes and bone marrow. T lymphocytes mature in the thymus. We classify leukemia and lymphoma according to their cell of origin. Tumors arising from the germinal center of lymphoid follicles in lymph nodes like: 1- Follicular lymphoma 2- Burkitt lymphoma 3- Diffuse large cell lymphoma Are these cells CD10 positive or negative? They re CD10 positive because they re germinal center lymphoma. What about mantle cell lymphoma, is it CD10 positive? No, because it doesn t arise from the germinal center. Are cells arising from marginal zone positive for CD20? Yes because marginal zone contains B lymphocytes. All B cell lymphoma are CD20 positive. Remember: Tumors arising from immature lymphoidcells called leukemiathis is also applied on lymphoid cells precursors (because they re immature). Acute lymphoblastic leukemia (ALL)is an example. It usually affects children and is curable. Chronic lymphocytic leukemia(cll): it s is leukemia but it s a composed of mature cells! Why? Same reason as Hairy cell leukemia (page 1). These cells arise from a stage before going inside the lymph node called naïve Blymphocyte. It usually affects adults. Recall that lymphocyte start differentiating in bone marrow, then they re released to the blood, and to complete their maturation, they go to lymph nodes. This stage after going out of bone marrow and before going into the lymph node is called naive Blymphocyte. 10 P a g e

12 After going inside the germinal center, the B lymphocyte matures into Plasma cell which can be present in lymph nodes or tissues but not in blood. A tumor arising from plasma cells is called: Plasma cell neoplasm (E.g. plasmacytoma, multiple myeloma... these arise from plasma cells)? Which one is aggressive and which one is indolent (in behavior) of CCL and ALL? The general rule is: Acute leukemia aggressive; bad with short survival, but if the patient is given the right treatment it may be curable. Chronicleukemia indolent; the patient can survive for years but the disease is non-curable 11 P a g e

13 B-Cell Neoplasm Again... neoplasm of mature cells are called lymphoma, whereas those of immature cells are called leukemia. But how can we differentiate between differentiated mature and undifferentiated cells? By morphology (like high N/c ratio) and antigen expression. That s why we have to know antigens associated with maturity and those associated with immaturity. For example, CD20: indicates a mature cell, CD3: its expression is early so it could be mature or immature. However, for immature primitive cells, we use 3 markers in general: CD34, TDT, CD117. (TDT is usually seen in acute lymphoblastic leukemia) So a cell expressing CD34 is immature primitive cell, it could be a leukemic or a stem cell. If you see a tumor that consists of cell expressing both CD20 and CD43, is this normal? Definitely no. Normal immature stem cells in our bone marrow express CD34 only. Normal mature cells should express mature markers only. Normal immature cells should express immature markersonly. If you have a cell expressing both abnormal leukemic cell. 12 P a g e

14 Immature B cell neoplasms In the figure above, there re tumors arising from precursor cells, we call them precursor cell lymphoblastic leukemia/lymphoma. Why lymphoma? Becauseyou can get the same tumor with the same antigen expression involving lymph nodes. So the same disease, if it involves the bone marrow we call it leukemia, whereas if it involves lymph nodes we call it lymphoma. Mature peripheral B cell neoplasms For mature peripheral B cell neoplasm there s B-cell CCL/SLL (chronic lymphocytic leukemia/ small lymphocytic lymphoma). Both of them involve mature cells (mentioned in page 10) So a patient with CLL will present to you with lymphocytosis. It s usually an incidental finding; you find it by chance. For example, if an elderly patient comes to do regular checkup, when you look for white blood count it s 50,000!! This high (leukocytosis) and there s no sign of infection. Then you draw a peripheral blood sample and find that those are mature cells. Then you do flow cytometry (to look for antigens) and find that those cells have mature B cell markers (mature B lymphocytes). How do you know if these cell are abnormal or not? By expression of other antigens. For example, if these B cells express CD5(which is a T cell marker) then this is abnormal clonal growth. CLL mature B cells expressing mature B cell markers but expressing CD5 which is a T cell marker. In small lymphocytic lymphoma SLL, the same disease as CLL but it involves lymph nodes. Just be familiar how the above examples are different and if they involve bone marrow or lymph nodes other examples are either leukemia or lymphoma, so no problem take it easy 13 P a g e

15 Marginal B cell neoplasm It could be: nodal: marginal zone lymphoma arising from the lymph node. OR Extra-nodal: marginal zone lymphoma arising from the spleen for example, we call it splenic marginal zone lymphoma. Follicular lymphoma: so called because it forms follicles Mantle B cell lymphoma: It arises from mantle zone. Diffuse large B cell lymphoma: If you look at the cells under the microscope you will see it s diffused, not forming nodules, and composed of large B lymphocytes. Previously, pathology was just a descriptive science; you see and describe, but now there re many bases for classification (E.g. genetic defects). Low grade B-cell NHL (non-hodgkin lymphoma) Includes marginal zone lymphoma, follicular lymphoma (stage 1), CLL and SLL. Small Lymphocytic Lymphoma SLL - so called because it is composed of small mature B lymphocytes - it s a low grade lymphoma - has a diffuse growth pattern; sheets of lymphocytes - If you look at a normal lymph node, you expect to see capsule, sub-capsular sinus, germinal canter, lymphoid follicles. However, if the lymph node is involved in SLL, you will see diffuse effacement of its architecture by sheets of lymphocytes. All what you see is lymphocytes, you don t see follicles... most of the lymph node is effaced by small lymphocyte... see next 14 P a g e

16 Capsule Here, in a normal lymph node you should see follicles, but the total architecture is replaced by small lymphocyte. (Refer to page 5 to see the normal LN). This is in case when small cells replace the architecture of a lymph node. On the other hand, if the cells are large we call it diffuse large B cell lymphoma Higher magnification As you see, all lymphocytes look mature, sometimes you may see some abnormal pro-lymphocytes. Looking at this image, by morphology, you can t differentiate between normal and lymphoma lymphocytes. So what will you do? You will look for architecture and antigens. You look for antigens using immune stains, by applying antibodies. If the antigen is there you will get antigen-antibody reaction and the stain will appear. These are peripheral blood cells. Also you can see mature-looking lymphocytes These are Smudge cells which are remnants of cells that lack any identifiable cytoplasmic membrane or nuclear structure. labce.com/spg48905_smudge_cells.aspx SLL is a B cell lymphoma, so it should express CD20 for example, and it doesn t arise from the germinal center. So if you do a CD10 test it should be negative for CD10 because it s not a germinal center lymphoma. There re also other markers that are specific for SLL: CD5 and CD P a g e

17 If a patient presented to you with more than 5000 lymphocytes in peripheral blood CLL But if a patient presented to you with the same disease with less than 5000 abnormal lymphocytes in peripheral blood and no bone marrow involvement SLL?If you want to know if a lymphocyte cell resulted monoclonal or polyclonal process, what dowe do? We look for Kappa (K) and Lambda (λ) light chains. - Normally in your body, there should be lymphocytes having K and others having λ polyclonal = normal - If all cell are expressing K or all cells are expressing λ this is abnormal monoclonal (Neoplastic) - Another example: In your peripheral blood you should have CD4 T cells and CD8 T cells too, but if all of the cells are CD4 abnormal: these clonal (neoplastic) cells replaced all other cells. As we said, these B cells express CD5 which is a T cell marker (due to genetic defect) By knowing all of the information above, we can that this is a small lymphocytic lymphoma or chronic lymphocytic leukemia 16 P a g e Remember: SLL & CLL are the same but differ in the site of involvement + # of lymphocytes in the peripheral blood

18 In lymphoma, bone marrow is invariably involved: less than 30% involvement If there s more than 30% bone marrow involvement Leukemia Typically, the patients are elderly with generalized lymphadenopathy and mild to moderate hepatosplenomegaly. B-Cell Chronic Lymphocytic Leukemia (CLL): - As we said it s the same disease as SLL. - Neoplasm of mature lymphocytes - Accumulation of mature B-lymphocytes in BM or PB - Epidemiology: Most common leukemia in West 30% of all leukemia Older adults (median age 70 y) CLL Clinical Features& pathology : Lymphadenopathy, Thrombocytopenia, Anemia etc. Peripheral blood: Lymphocytosis >5,000 per μl (CLL lymphocytes) Or >30% bone marrow involvement CD10-(because it s a non-germinal center lymphoma), CD19+, CD20+, CD23+, CD5+, sig+ (clonal) - Anemia, Thrombocytopenia 17 P a g e

19 Transformation from low grad (indolent) to high grade (aggressive) lymphoma is possible, it s called Richter transformation. For CLL, it may transform into aggressive lymphoma which is Diffuse large B cell lymphoma: If you have a 70 year old patient, and you diagnose him with chronic lymphocytic lymphoma, and the patient is okay because this is chronic indolent disease. However, this patient may come to you after 3 years complaining of weight loss, fever, sudden lymph node enlargement. You then look at the peripheral blood sample and you see a new lymphoma composed of LARGE cells The reason behind this is that additional genetic defects occurred in addition to the base one and that caused transformation of CLL into diffuse large B cell lymphoma. Done Good luck and do your best Edited by Farah Bani Hani 18 P a g e

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour 7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic

More information

Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU

Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU Lecture outline Time 10:00 11:00 11:15 12:10 12:20 13:15 Content Introduction to lymphoma Review of lymphocyte biology

More information

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Lymphoid Neoplasms: 1- non-hodgkin lymphomas (NHLs) 2- Hodgkin lymphoma 3- plasma cell neoplasms Non-Hodgkin lymphomas (NHLs) Acute Lymphoblastic Leukemia/Lymphoma

More information

Plasma cell myeloma (multiple myeloma)

Plasma cell myeloma (multiple myeloma) Plasma cell myeloma (multiple myeloma) Common lymphoid neoplasm, present at old age (70 years average) Remember: plasma cells are terminally differentiated B-lymphocytes that produces antibodies. B-cells

More information

Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s

Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s Non Hodgkin s Lymphoma Introduction 6th most common cause of cancer death in United States. Increasing in incidence and mortality. Since 1970, the incidence of has almost doubled. Overview The types of

More information

Low grade High grade , immune suppression chronic persistent inflammation viruses B-symptoms

Low grade High grade , immune suppression chronic persistent inflammation viruses B-symptoms We've one category for lymphoid neoplasm which is the lymphoma in contrast to that of myeloid which has three categories; acute myeloid leukemias, myeloproliferative & myelodysplastic disorders. Lymphoma

More information

The Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D.

The Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D. The Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D. OBJECTIVES 1. To understand how ordered Ig gene rearrangements lead to the development

More information

Immunopathology of Lymphoma

Immunopathology of Lymphoma Immunopathology of Lymphoma Noraidah Masir MBBCh, M.Med (Pathology), D.Phil. Department of Pathology Faculty of Medicine Universiti Kebangsaan Malaysia Lymphoma classification has been challenging to pathologists.

More information

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital Lymphoma/CLL 101: Know your Subtype Dr. David Macdonald Hematologist, The Ottawa Hospital Function of the Lymph System Lymph Node Lymphocytes B-cells develop in the bone marrow and influence the immune

More information

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD WBCs Disorders 1 Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features

More information

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Heme 8 Burkitt lymphoma Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Most common is t(8;14) Believed to be the fastest growing tumor in humans!!!! Morphology

More information

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Parts 2 and 3

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Parts 2 and 3 HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD Parts 2 and 3 NEOPLASTIC LYMPHOID DISEASES Introduction o The bone marrow is the source of all cells in the

More information

LYMPHOMAS an overview of some subtypes of NHLs

LYMPHOMAS an overview of some subtypes of NHLs One of the confusing aspects of the lymphoid neoplasms concerns the use of the descriptive terms "leukemia" and "lymphoma." LYMPHOMAS an overview of some subtypes of NHLs Leukemia is used for lymphoid

More information

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing

More information

Understanding your diagnosis. Dr Graham Collins Consultant Haemtologist Oxford University Hospitals

Understanding your diagnosis. Dr Graham Collins Consultant Haemtologist Oxford University Hospitals Understanding your diagnosis Dr Graham Collins Consultant Haemtologist Oxford University Hospitals Common questions I get asked What is lymphoma? What subtype do I have and what does that mean? What are

More information

Prepared by: Dr.Mansour Al-Yazji

Prepared by: Dr.Mansour Al-Yazji C L L CLL Prepared by: Abd El-Hakeem Abd El-Rahman Abu Naser Ahmed Khamis Abu Warda Ahmed Mohammed Abu Ghaben Bassel Ziad Abu Warda Nedal Mostafa El-Nahhal Dr.Mansour Al-Yazji LEUKEMIA Leukemia is a form

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue Pathology of Hematopoietic and Lymphoid tissue Peerayut Sitthichaiyakul, M.D. Department of Pathology and Forensic Medicine Faculty of Medicine, Naresuan University CONTENTS White blood cells and lymph

More information

Lymphatic system component

Lymphatic system component Introduction Lymphatic system component Statistics Overview Lymphoma Non Hodgkin s Lymphoma Non- Hodgkin's is a type of cancer that originates in the lymphatic system. It is estimated to be the sixth most

More information

Development of B and T lymphocytes

Development of B and T lymphocytes Development of B and T lymphocytes What will we discuss today? B-cell development T-cell development B- cell development overview Stem cell In periphery Pro-B cell Pre-B cell Immature B cell Mature B cell

More information

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008 MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA April 16, 2008 FACULTY COPY GOAL: Learn the appearance of normal peripheral blood elements and lymph nodes. Recognize abnormal peripheral blood

More information

Case 3. Ann T. Moriarty,MD

Case 3. Ann T. Moriarty,MD Case 3 Ann T. Moriarty,MD Case 3 59 year old male with asymptomatic cervical lymphadenopathy. These images are from a fine needle biopsy of a left cervical lymph node. Image 1 Papanicolaou Stained smear,100x.

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue CONTENTS Pathology of Hematopoietic and Lymphoid tissue White blood cells and lymph nodes Quantitative disorder of white blood cells Reactive lymphadenopathies Infectious lymphadenitis Tumor metastasis

More information

Flow cytometric analysis of B-cell lymphoproliferative disorders

Flow cytometric analysis of B-cell lymphoproliferative disorders Flow cytometric analysis of B-cell lymphoproliferative disorders David M. Dorfman, M.D., Ph.D. Department of Pathology Brigham and Women s Hospital and Harvard Medical School Boston, MA Objectives Review

More information

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Classification of Hematologic Malignancies. Patricia Aoun MD MPH Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences

More information

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16 35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will

More information

Lymphoid tissue. 1. Central Lymphoid tissue. - The central lymphoid tissue (also known as primary) is composed of bone morrow and thymus.

Lymphoid tissue. 1. Central Lymphoid tissue. - The central lymphoid tissue (also known as primary) is composed of bone morrow and thymus. 1. Central Lymphoid tissue Lymphoid tissue - The central lymphoid tissue (also known as primary) is composed of bone morrow and thymus. Bone Morrow - The major site of hematopoiesis in humans. - Hematopoiesis

More information

88-year-old Female with Lymphadenopathy. Faizi Ali, MD

88-year-old Female with Lymphadenopathy. Faizi Ali, MD 88-year-old Female with Lymphadenopathy Faizi Ali, MD Clinical History A 88-year-old caucasian female presented to our hospital with the complaints of nausea, vomiting,diarrhea, shortness of breath and

More information

WHO Classification. B-cell chronic lymphocytic leukemia/small T-cell granular lymphocytic leukemia

WHO Classification. B-cell chronic lymphocytic leukemia/small T-cell granular lymphocytic leukemia Blood Malignancies-II Prof. Dr. Herman Hariman, a Ph.D, SpPK (KH). Prof. Dr. Adikoesoema Aman, SpPK (KH) Dept. of Clinical Pathology, School of Medicine, University of North Sumatra WHO classification

More information

Patterns of Lymphoid Neoplasia in Peripheral Blood. Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure

Patterns of Lymphoid Neoplasia in Peripheral Blood. Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure Patterns of Lymphoid Neoplasia in Peripheral Blood Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure Dr Baltrucki has received an honorarium for his participation as a faculty presenter in this

More information

Small B-cell (Histologically Low Grade) Lymphoma

Small B-cell (Histologically Low Grade) Lymphoma Frequency of Lymphoid Neoplasms Small B-cell (Histologically Low Grade) Lymphoma Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital B-cell neoplasms 88% Diffuse large B-cell lymphoma

More information

FOLLICULARITY in LYMPHOMA

FOLLICULARITY in LYMPHOMA FOLLICULARITY in LYMPHOMA Reactive Follicular Hyperplasia Follicular Hyperplasia irregular follicles Follicular Hyperplasia dark and light zones Light Zone Dark Zone Follicular hyperplasia MIB1 Follicular

More information

Contents. vii. Preface... Acknowledgments... v xiii

Contents. vii. Preface... Acknowledgments... v xiii Contents Preface... Acknowledgments... v xiii SECTION I 1. Introduction... 3 Knowledge-Based Diagnosis... 4 Systematic Examination of the Lymph Node... 7 Cell Type Identification... 9 Cell Size and Cellularity...

More information

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Differential diagnosis of hematolymphoid tumors composed of medium-sized cells Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Lymphoma classification Lymphoma diagnosis starts with morphologic

More information

LYMPH GLAND. By : Group 1

LYMPH GLAND. By : Group 1 LYMPH GLAND By : Group 1 ANATOMY LYMPH NODE Lymphatic Organs Red bone marrow Thymus gland Lymph nodes Lymph nodules Spleen Primary organs Secondary organs Lymph Nodes Firm, smooth-surfaced, bean-shaped

More information

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009 LEUKEMIA CHAPTER:4 1 BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of

More information

Pathology of the Lymphoid System

Pathology of the Lymphoid System Pathology of the Lymphoid System Learning Objectives: Define lymphadenitis and enumerate its types. Briefly describe the morphological appearance of reactive lymph node. Describe the microscopic picture

More information

The development of clonality testing for lymphomas in the Bristol Genetics Laboratory. Dr Paula Waits Bristol Genetics Laboratory

The development of clonality testing for lymphomas in the Bristol Genetics Laboratory. Dr Paula Waits Bristol Genetics Laboratory The development of clonality testing for lymphomas in the Bristol Genetics Laboratory Dr Paula Waits Bristol Genetics Laboratory Introduction The majority of lymphoid malignancies belong to the B cell

More information

11/8/2018 DISCLOSURES. I have NO Conflicts of Interest to Disclose. UTILTY OF DETECTING PATTERNS

11/8/2018 DISCLOSURES. I have NO Conflicts of Interest to Disclose. UTILTY OF DETECTING PATTERNS Bharat N. Nathwani, M.D. City of Hope Medical Center Professor, Director of Pathology Consultation Services, 1500 East Duarte Road, Duarte, California, 91010 DISCLOSURES -------------------------------------------------------

More information

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative

More information

Overview B cell development T cell development

Overview B cell development T cell development Topics Overview B cell development T cell development Lymphocyte development overview (Cont) Receptor diversity is produced by gene rearrangement and is random Includes specificities that will bind to

More information

WBCs Disorders. Dr. Nabila Hamdi MD, PhD

WBCs Disorders. Dr. Nabila Hamdi MD, PhD WBCs Disorders Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features and

More information

Non-Hodgkin Lymphoma. Protocol applies to non-hodgkin lymphoma involving any organ system except the gastrointestinal tract.

Non-Hodgkin Lymphoma. Protocol applies to non-hodgkin lymphoma involving any organ system except the gastrointestinal tract. Non-Hodgkin Lymphoma Protocol applies to non-hodgkin lymphoma involving any organ system except the gastrointestinal tract. Protocol revision date: January 2005 No AJCC/UICC staging system Procedures Cytology

More information

Immunology 2017: Lecture 12 handout. Secondary lymphoid organs. Dr H Awad

Immunology 2017: Lecture 12 handout. Secondary lymphoid organs. Dr H Awad Immunology 2017: Lecture 12 handout Secondary lymphoid organs Dr H Awad INTRODUCTION So far we discussed the cells of the immune system and how they recognize their antigens and get stimulated. The number

More information

Monsanto s Spin on its Roundup herbicide is Unwinding

Monsanto s Spin on its Roundup herbicide is Unwinding Monsanto s Spin on its Roundup herbicide is Unwinding By: Thomas T. Dunbar, Esq. Recently, information about the potential danger posed by Monsanto s Roundup has surfaced as a result of information discovered

More information

The spectrum of flow cytometry of the bone marrow

The spectrum of flow cytometry of the bone marrow The spectrum of flow cytometry of the bone marrow Anna Porwit Lund University Faculty of Medicine Dept. of Clinical Sciences Div. Oncology and Pathology anna.porwit@med.lu.se Disclosure of speaker s interests

More information

V. Acute leukemia. Flow cytometry in evaluation of hematopoietic neoplasms: A case-based approach

V. Acute leukemia. Flow cytometry in evaluation of hematopoietic neoplasms: A case-based approach V. Acute leukemia Evaluating a sample for an acute leukemia Acute leukemia is a neoplasm of immature myeloid or lymphoid cells characterized by a block in maturation, usually at the stage of an early progenitor

More information

Lymphoma Update: Lymphoma Update: What s Likely to be New in the New WHO. Patrick Treseler, MD, PhD University of California San Francisco

Lymphoma Update: Lymphoma Update: What s Likely to be New in the New WHO. Patrick Treseler, MD, PhD University of California San Francisco Lymphoma Update: What s Likely to be New in the New WHO Blood 127:2375; 2016 Patrick Treseler, MD, PhD University of California San Francisco Lymphoma Update: What IS New in the New WHO! Patrick Treseler,

More information

Pathology of the Lymphoid System

Pathology of the Lymphoid System Pathology of the Lymphoid System Learning Objectives: Define lymphadenitis and enumerate its types. Briefly describe the morphological appearance of reactive lymph node. Describe the microscopic picture

More information

Classifications of lymphomas

Classifications of lymphomas Classifications of lymphomas Lukes and Collins Kiel classification Working formulation REAL classification (1994) WHO classification (2000) WHO CLASSIFICATIONF OF NEOPLASMS HAEMATOPETIC AND LYMPHOID TISSUES

More information

Lymphoma and Myeloma Kris3ne Kra4s, M.D.

Lymphoma and Myeloma Kris3ne Kra4s, M.D. Lymphoma and Myeloma Kris3ne Kra4s, M.D. Hematologic Malignancies Leukemia Malignancy of hematopoie3c cells Starts in bone marrow, can spread to blood, nodes Myeloid or lymphoid Acute or chronic Lymphoma

More information

A Practical Guide To Diagnose B-Cell Lymphomas on FNAs. Nancy P. Caraway, M.D.

A Practical Guide To Diagnose B-Cell Lymphomas on FNAs. Nancy P. Caraway, M.D. A Practical Guide To Diagnose B-Cell Lymphomas on FNAs Nancy P. Caraway, M.D. Major Factors Impacting Dx Lymphomas on Small Bxs Classification systems Immunophenotyping by multiprobe flow cytometry and

More information

HIGH GRADE B-CELL LYMPHOMA DAVID NOLTE, MD (PGY-2) HUSSAM AL-KATEB, PHD, FACMG DEBORAH FUCHS, MD

HIGH GRADE B-CELL LYMPHOMA DAVID NOLTE, MD (PGY-2) HUSSAM AL-KATEB, PHD, FACMG DEBORAH FUCHS, MD HIGH GRADE B-CELL LYMPHOMA DAVID NOLTE, MD (PGY-2) HUSSAM AL-KATEB, PHD, FACMG DEBORAH FUCHS, MD OUTLINE High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements Patient presentation 2008/2016

More information

Test Utilization: Chronic Lymphocytic Leukemia

Test Utilization: Chronic Lymphocytic Leukemia Test Utilization: Chronic Lymphocytic Leukemia Initial Evaluation Diagnostic Criteria Selection of Tests for Prognosis Response to Therapy Challenges Assessment for persistent disease Paul J. Kurtin, M.D.

More information

The Lymphatic System

The Lymphatic System The Lymphatic System The Lymphatic Systems Overview General Functions Organization Components Lymphatic System General Functions Transportation Excess fluid from capillary exchange Fats & fat soluble vitamins

More information

Lymphatic and Immune Systems

Lymphatic and Immune Systems Lymphatic and Immune www.vastaccess.com 2 Specialized component of circulatory system Lymphatic system functions: Maintenance of internal fluid balance Immunity Lymph derived from blood and tissue fluid

More information

LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center

LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center Lymphoma is cancer of the lymphatic system. The lymphatic system is made up of organs all over the body that make up and store cells

More information

Neoplastic proliferation arising from white blood cells. Introductory remarks. Classification

Neoplastic proliferation arising from white blood cells. Introductory remarks. Classification Neoplastic proliferation arising from white blood cells Lymphoproliferative and myeloproliferative diseases and syndromes Oliver Rácz, 2012-2017 1 Introductory remarks Leukemia and lymphoma are old descriptive

More information

Leukemias and Lymphomas Come From Normal Blood Cells

Leukemias and Lymphomas Come From Normal Blood Cells Leukemias and Lymphomas Come From Normal Blood Cells by Steve Anderson, Ph.D. Steve Anderson has a Ph.D. in Immunology with 25 years experience in biomedical research. His scientific expertise includes

More information

Hematopathology Specialty Conference Case #1

Hematopathology Specialty Conference Case #1 Hematopathology Specialty Conference Case #1 Robert (Bob) Ohgami, MD, PhD Assistant Professor Stanford University Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships

More information

Pathology of the indolent B-cell lymphomas Elias Campo

Pathology of the indolent B-cell lymphomas Elias Campo Pathology of the indolent B-cell lymphomas Elias Campo Hospital Clinic, University of Barcelona Small B-cell lymphomas Antigen selection NAIVE -B LYMPHOCYTE MEMORY B-CELL MCL FL LPL MZL CLL Small cell

More information

GENETIC MARKERS IN LYMPHOMA a practical overview. P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute

GENETIC MARKERS IN LYMPHOMA a practical overview. P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute GENETIC MARKERS IN LYMPHOMA a practical overview P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute B and T cell monoclonalities Rearrangement of immunoglobin and TCR genes may help

More information

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED Acute Myeloid Leukemia Firstly we ll start with this introduction then enter the title of the lecture, so be ready and let s begin by the name of Allah : We

More information

Hematopoiesis. Hematopoiesis. Hematopoiesis

Hematopoiesis. Hematopoiesis. Hematopoiesis Chapter. Cells and Organs of the Immune System Hematopoiesis Hematopoiesis- formation and development of WBC and RBC bone marrow. Hematopoietic stem cell- give rise to any blood cells (constant number,

More information

DETERMINATION OF A LYMPHOID PROCESS

DETERMINATION OF A LYMPHOID PROCESS Chapter 2 Applications of Touch Preparation Cytology to Intraoperative Consultations: Lymph Nodes and Extranodal Tissues for Evaluation of Hematolymphoid Disorders INTRODUCTION As discussed in Chap. 1,

More information

Lymphoid Neoplasms. Sylvie Freeman Department of Clinical Immunology, University of Birmingham

Lymphoid Neoplasms. Sylvie Freeman Department of Clinical Immunology, University of Birmingham Lymphoid Neoplasms Sylvie Freeman Department of Clinical Immunology, University of Birmingham Incidence of Haematological Malignancies UK2001 (CRUK) Malignancy New Cases All Cancers 271,000 Leukaemia 6,760

More information

Methods used to diagnose lymphomas

Methods used to diagnose lymphomas Institut für Pathologie Institut für Pathologie Methods used to diagnose lymphomas Prof. Dr.Med. Leticia Quintanilla-Fend Molecular techniques NGS histology Cytology AS-PCR Sanger seq. MYC Immunohistochemistry

More information

Reactive and Neoplastic Lymphocytosis

Reactive and Neoplastic Lymphocytosis Reactive and Neoplastic Lymphocytosis Koranda A. Walsh, VMD, BS Assistant Professor, Clinical Pathobiology University of Pennsylvania School of Veterinary Medicine PLEASE NOTE: These notes are meant as

More information

LYMPHOID ORGANS. Dr. Iram Tassaduq

LYMPHOID ORGANS. Dr. Iram Tassaduq LYMPHOID ORGANS Dr. Iram Tassaduq COMPONENTS OF IMMUNE SYSTEM Lymphocytes Diffuse Lymphatic Tissue Lymphatic Nodules Lymph node Spleen Bone marrow Thymus Functions of Immune System Has the ability to distinguish

More information

B cell activation and antibody production. Abul K. Abbas UCSF

B cell activation and antibody production. Abul K. Abbas UCSF 1 B cell activation and antibody production Abul K. Abbas UCSF 2 Lecture outline B cell activation; the role of helper T cells in antibody production Therapeutic targeting of B cells 3 Principles of humoral

More information

Lymphoma Read with the experts

Lymphoma Read with the experts Lymphoma Read with the experts Marc Seltzer, MD Associate Professor of Radiology Geisel School of Medicine at Dartmouth Director, PET-CT Course American College of Radiology Learning Objectives Recognize

More information

Overview of Cutaneous Lymphomas: Diagnosis and Staging. Lauren C. Pinter-Brown MD, FACP Health Sciences Professor of Medicine and Dermatology

Overview of Cutaneous Lymphomas: Diagnosis and Staging. Lauren C. Pinter-Brown MD, FACP Health Sciences Professor of Medicine and Dermatology Overview of Cutaneous Lymphomas: Diagnosis and Staging Lauren C. Pinter-Brown MD, FACP Health Sciences Professor of Medicine and Dermatology Definition of Lymphoma A cancer or malignancy that comes from

More information

Diagnosis of lymphoid neoplasms has been

Diagnosis of lymphoid neoplasms has been Iranian Journal of Pathology (2007)2 (1), 1-61 Review Article Mehdi Nassiri Dep. of Pathology, University of Miami Miller School of Medicine, Miami, USA Abstract Correct diagnosis and classification of

More information

Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113)

Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113) Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the CLL Post-HSCT Data Form. E-mail

More information

Daratumumab, a novel human CD38 monoclonal antibody for the treatment of B cell Non Hodgkin Lymphoma

Daratumumab, a novel human CD38 monoclonal antibody for the treatment of B cell Non Hodgkin Lymphoma Daratumumab, a novel human CD38 monoclonal antibody for the treatment of B cell Non Hodgkin Lymphoma Anna Vidal Department of Hemato Oncology IDIBAPS, Barcelona, Spain B cell lymphoid malignancies seen

More information

The patient had a mild splenomegaly but no obvious lymph node enlargement. The consensus phenotype obtained from part one of the exercise was:

The patient had a mild splenomegaly but no obvious lymph node enlargement. The consensus phenotype obtained from part one of the exercise was: Case History An 86 year old male was admitted to hospital with chest infection. Haematological examination subsequently revealed the following: Hb- 11.0 g/dl; WBC- 67.1 x 10^9/l; PLT- 99 x10^9/l; RBC-

More information

Lymphocytoma Cutis. Cynthia M. Magro MD. Director of Dermatopathology Weill Medical College of Cornell University New York, New York

Lymphocytoma Cutis. Cynthia M. Magro MD. Director of Dermatopathology Weill Medical College of Cornell University New York, New York Lymphocytoma Cutis Cynthia M. Magro MD Professor of Pathology Director of Dermatopathology Weill Medical College of Cornell University New York, New York Lymphocytoma Cutis Falls under other designations

More information

Leukemia And Lymphoma In The Nervous System

Leukemia And Lymphoma In The Nervous System Leukemia And Lymphoma In The Nervous System If you are searching for the book Leukemia and Lymphoma in the Nervous System in pdf format, then you've come to the right site. We presented complete variant

More information

Lymphoma: The Basics. Dr. Douglas Stewart

Lymphoma: The Basics. Dr. Douglas Stewart Lymphoma: The Basics Dr. Douglas Stewart Objectives What is lymphoma? How common is it? Why does it occur? How do you diagnose it? How do you manage it? How do you follow patients after treatment? What

More information

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University LEUKAEMIA and LYMPHOMA Dr Mubarak Abdelrahman Assistant Professor Jazan University OBJECTIVES Identify etiology and epidemiology for leukemia and lymphoma. Discuss common types of leukemia. Distinguish

More information

Hematopathology Lab. Third year medical students

Hematopathology Lab. Third year medical students Hematopathology Lab Third year medical students Objectives Identify the lesion Know the specific name of the lesion Know associated disease Know relevant pathologic background Spherocytes: appear small,

More information

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor I. Description of the rotation: During this rotation, the resident will gain

More information

MCAT Biology - Problem Drill 16: The Lymphatic and Immune Systems

MCAT Biology - Problem Drill 16: The Lymphatic and Immune Systems MCAT Biology - Problem Drill 16: The Lymphatic and Immune Systems Question No. 1 of 10 1. Which of the following statements about pathogens is true? Question #01 (A) Both viruses and bacteria need to infect

More information

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic

More information

Infections and nonmicrobial inflammatory stimuli can cause leukocytosis (as seen in Lab 1) as well as lymph node enlargement (lymphadenopathy).

Infections and nonmicrobial inflammatory stimuli can cause leukocytosis (as seen in Lab 1) as well as lymph node enlargement (lymphadenopathy). LAB 5: LYMPHOID TISSUE AND SKIN The focus of this week s lab will be pathology of the lymphoid tissue and skin. The lymphoid organs include the thymus, spleen, and lymph nodes. Abnormalities in the lymph

More information

Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent

Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent Int J Clin Exp Med 2014;7(1):307-311 www.ijcem.com /ISSN:1940-5901/IJCEM1311029 Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent Qilin Ao 2, Ying Wang 1, Sanpeng Xu 2,

More information

Immunohistochemical classification of haematolymphoid tumours. Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital

Immunohistochemical classification of haematolymphoid tumours. Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital Immunohistochemical classification of haematolymphoid tumours Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital Malignant lymphoproliferative diseases What are they? Haematolymphoid

More information

Case Report Parotid gland follicular lymphoma lacking both cytoplasmic and surface light chains: a rare case

Case Report Parotid gland follicular lymphoma lacking both cytoplasmic and surface light chains: a rare case Int J Clin Exp Pathol 2014;7(10):7100-7104 www.ijcep.com /ISSN:1936-2625/IJCEP0001717 Case Report Parotid gland follicular lymphoma lacking both cytoplasmic and surface light chains: a rare case Jenny

More information

NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary)

NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary) NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Michelle Geddes (Staff Hematologist, University of Calgary) and Dr.

More information

Andrea s SI Session PCB Practice Test Test 3

Andrea s SI Session PCB Practice Test Test 3 Practice Test Test 3 READ BEFORE STARTING PRACTICE TEST: Remember to please use this practice test as a tool to measure your knowledge, and DO NOT use it as your only tool to study for the test, since

More information

Q&A Session Collecting Cancer Data: Hematopoietic and Lymphoid Neoplasms Thursday, November 6, 2014

Q&A Session Collecting Cancer Data: Hematopoietic and Lymphoid Neoplasms Thursday, November 6, 2014 Q&A Session Collecting Cancer Data: Hematopoietic and Lymphoid Neoplasms Thursday, November 6, 2014 Q: If polycythemia ruba vera (PRV) or essential thrombocythemia (ET) is diagnosed by peripheral smear,

More information

Chapter 3 Hematopathology 63. Hematopathology CHAPTER

Chapter 3 Hematopathology 63. Hematopathology CHAPTER Chapter 3 Hematopathology 63 Hematopathology CHAPTER 3 64 Chapter 3 Hematopathology * FIGURE 3 1 Normal lymph node, This benign reactive lymph node has a welldefined connective tissue capsule ( ), and

More information

9/28/2017. Follicular Lymphoma and Nodal Marginal Zone Lymphoma. Follicular Lymphoma Definition. Low-Grade B-Cell Lymphomas in WHO Classification

9/28/2017. Follicular Lymphoma and Nodal Marginal Zone Lymphoma. Follicular Lymphoma Definition. Low-Grade B-Cell Lymphomas in WHO Classification and L. Jeffrey Medeiros, MD DISCLOSURES I do not have anything to disclose Low-Grade B-Cell Lymphomas in WHO Classification Lymphoma Type Frequency Follicular lymphoma 22.1 % Extranodal MALT-lymphoma 7.6

More information

Gray Zones and Double Hits Distinguishing True Burkitt Lymphoma from Other High-Grade B-NHLs Burkitt Lymphoma Burkitt-Like Lymphoma DLBCL Patrick Tres

Gray Zones and Double Hits Distinguishing True Burkitt Lymphoma from Other High-Grade B-NHLs Burkitt Lymphoma Burkitt-Like Lymphoma DLBCL Patrick Tres Gray Zones and Double Hits Distinguishing True Burkitt Lymphoma from Other High-Grade B-NHLs Burkitt Lymphoma Burkitt-Like Lymphoma DLBCL Patrick Treseler, MD, PhD University of California San Francisco

More information

Defensive mechanisms include :

Defensive mechanisms include : Acquired Immunity Defensive mechanisms include : 1) Innate immunity (Natural or Non specific) 2) Acquired immunity (Adaptive or Specific) Cell-mediated immunity Humoral immunity Two mechanisms 1) Humoral

More information

Indolent Lymphomas. Dr. Melissa Toupin The Ottawa Hospital

Indolent Lymphomas. Dr. Melissa Toupin The Ottawa Hospital Indolent Lymphomas Dr. Melissa Toupin The Ottawa Hospital What does indolent mean? Slow growth Often asymptomatic Chronic disease with periods of relapse (long natural history possible) Incurable with

More information

CD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting

CD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting Original Article DOI: 10.21276/APALM.1364 CD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting Sakthi Sankari S 1 *, Arjunan A 2, Bhuvaneswari M.G. 2, Sindhuja

More information

Low-grade B-cell lymphoma

Low-grade B-cell lymphoma Low-grade B-cell lymphoma Patho-Basic 11. September 2018 Stephan Dirnhofer Pathology Outline Definition LPL, MBL/CLL/SLL, MCL FL Subtypes & variants Diagnosis including Grading Transformation Summary Be

More information

Leukocytosis - Some Learning Points

Leukocytosis - Some Learning Points Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful

More information

Hematology 101. Rachid Baz, M.D. 5/16/2014

Hematology 101. Rachid Baz, M.D. 5/16/2014 Hematology 101 Rachid Baz, M.D. 5/16/2014 Florida 101 Epidemiology Estimated prevalence 8,000 individuals in U.S (compare with 80,000 MM patients) Annual age adjusted incidence 3-8/million-year 1 More

More information

Innate immunity (rapid response) Dendritic cell. Macrophage. Natural killer cell. Complement protein. Neutrophil

Innate immunity (rapid response) Dendritic cell. Macrophage. Natural killer cell. Complement protein. Neutrophil 1 The immune system The immune response The immune system comprises two arms functioning cooperatively to provide a comprehensive protective response: the innate and the adaptive immune system. The innate

More information